| Rank | Ticker | Country | Price | Revenue | Analyst Rating | Analysts | IPO Year |
|---|---|---|---|---|---|---|---|
#1 | KRG | United States | $24.83 | $844,365,000.00 | Buy | 10 | 2004 |
#2 | QNST | United States | $14.42 | $282,140,000.00 | Buy | 4 | 2009 |
#3 | AA | United States | $42.77 | $12,831,000,000.00 | Buy | 10 | 2016 |
#4 | RSI | United States | $19.92 | $1,134,428,000.00 | Strong Buy | 10 | 2020 |
#5 | IVT | United States | $30.55 | $299,169,000.00 | Buy | 7 | 2005 |
#6 | AMCR | Switzerland | $42.51 | $13,640,000,000.00 | Strong Buy | 8 | 2020 |
#7 | NFG | United States | $79.06 | $2,277,541,000.00 | Buy | 4 | 1998 |
#8 | KEY | United States | $20.59 | $7,513,000,000.00 | Buy | 15 | 2005 |
#9 | SON | United States | $50.08 | $7,518,753,000.00 | Buy | 9 | 2014 |
#10 | SMG | United States | $50.97 | $3,016,500,000.00 | Buy | 6 | 2012 |
#11 | CSTM | France | $24.92 | $8,449,000,000.00 | Strong Buy | 4 | 2012 |
#12 | FAF | United States | $66.16 | $7,452,200,000.00 | Strong Buy | 4 | 2009 |
#13 | PAGP | United States | $26.59 | $44,262,000,000.00 | Buy | 10 | 2013 |
#14 | SHAK | United States | $55.58 | $1,445,306,000.00 | Buy | 26 | 2014 |
#15 | PRMB | United States | $19.54 | $6,664,000,000.00 | Buy | 9 | 2025 |
#16 | TRUP | United States | $23.15 | $1,439,305,000.00 | Buy | 5 | 2014 |
#17 | ASB | United States | $29.43 | $1,102,756,000.00 | Buy | 12 | 2014 |
#18 | PTCT | United States | $62.85 | $264,734,000.00 | Buy | 17 | 2006 |
#19 | DAN | United States | $27.17 | $7,500,000,000.00 | Buy | 5 | 2003 |
#20 | RELY | United States | $21.39 | $1,635,147,000.00 | Buy | 7 | 2021 |
#21 | KNSA | United Kingdom | $75.22 | $677,564,000.00 | Strong Buy | 7 | 2018 |
#22 | QTWO | United States | $56.27 | $193,978,000.00 | Buy | 11 | 2014 |
#23 | PACS | United States | $41.22 | $5,288,932,000.00 | Strong Buy | 4 | 2024 |
#24 | BJRI | United States | $60.21 | $0.00 | Buy | 8 | 1996 |
#25 | BKV | United States | $21.87 | $893,781,000.00 | Strong Buy | 9 | 2022 |
#26 | EVER | United States | $18.64 | $163,349,000.00 | Strong Buy | 5 | 2018 |
#27 | OOMA | United States | $21.80 | $114,490,000.00 | Strong Buy | 4 | 2015 |
#28 | VTR | United States | $86.63 | $5,833,980,000.00 | Buy | 13 | 2005 |
#29 | FRPT | United States | $57.79 | $1,102,015,000.00 | Buy | 17 | 2014 |
#30 | BMY | United States | $62.88 | $48,194,000,000.00 | Buy | 15 | 2006 |
#31 | AORT | United States | $22.70 | $298,836,000.00 | Strong Buy | 5 | 1996 |
#32 | ZVRA | United States | $11.05 | $106,470,000.00 | Strong Buy | 5 | 2015 |
#33 | KNTK | United States | $51.22 | $160,617,000.00 | Buy | 12 | 2017 |
#34 | CALX | United States | $33.22 | $510,367,000.00 | Strong Buy | 5 | 2009 |
#35 | BXMT | United States | $12.53 | $0.00 | Buy | 5 | 1998 |
#36 | NTST | United States | $18.27 | $195,006,000.00 | Strong Buy | 14 | 2020 |
#37 | APEI | United States | $41.69 | $198,174,000.00 | Strong Buy | 7 | 2007 |
#38 | SIRI | United States | $25.93 | $5,425,129,000.00 | Buy | 8 | 1996 |
#39 | CPT | United States | $98.37 | $12,967,000.00 | Buy | 17 | 1995 |
#40 | UMH | United States | $15.42 | $261,754,000.00 | Strong Buy | 4 | 1995 |
#41 | UPST | United States | $23.87 | $1,043,857,000.00 | Buy | 16 | 2020 |
#42 | HQY | United States | $88.30 | $229,525,000.00 | Buy | 14 | 2014 |
#43 | LTH | United States | $40.07 | $2,995,255,000.00 | Strong Buy | 7 | 2021 |
#44 | SWX | United States | $82.62 | $5,433,972,000.00 | Strong Buy | 5 | 2017 |
#45 | PGY | United States | $17.62 | $1,301,360,000.00 | Strong Buy | 8 | 2021 |
#46 | CCI | United States | $67.83 | $4,264,000,000.00 | Buy | 16 | 1998 |
#47 | DCTH | United States | $15.60 | $0.00 | Strong Buy | 4 | 2015 |
#48 | EPD | United States | $36.98 | $52,596,000,000.00 | Buy | 14 | 1998 |
#49 | EPR | United States | $56.99 | $718,357,000.00 | Buy | 9 | 1997 |
#50 | NVST | United States | $23.91 | $2,566,500,000.00 | Buy | 13 | 2019 |
The FinQuota filters have identified what they believe to be the "Best Stocks Under $100 to Buy (September 26, 2026) | FinQuota" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.